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PATHOGENIC ASPECTS OF THE SALI-
VARY GLANDS
Primary Sjögren’s syndrome (SS) is generally
considered to be a T cell-mediated autoimmune dis-
order characterized by lymphocytic infiltrates and
destruction of the salivary glands, and systemic pro-
duction of autoantibodies to the ribonucleoprotein
(RNP) particles SS-A/Ro and SS-B/La (1-3). It is
assumed that autoreactive T cells bearing CD4
molecule may recognize unknown autoantigen trig-
gering autoimmunity in the salivary glands, lead-
ing to clinical symptoms of dryness of the mouth
and eyes (sicca syndrome)(4) Despite extensive
study of the underlying cause of SS, the pathogene-
sis remains obscure. A combination of immunologic,
genetic, and environmental factors may play a key
role on development of autoimmune lesions in the
salivary glands (4). Moreover, the histopathology
of human SS is not fully understood. Lymphocytes
first surround the salivary ducts and then extend
into the acinar epithelium, leading to diminished
glandular secretion as a result of apoptosis. Id3 is
an early response gene involved in T cell receptor-
mediated cell selection, and it is reported that Id3
knockout mice develop autoimmune lesions simi-
lar to SS and adoptive transfer of Id3 knockout T
cells caused SS in non-susceptible mice (5). Indeed,
epithelial cell activation has been proposed to be
the major pathological process in SS with increased
expression of class II antigens, and Fas on epithe-
lial cells in this disease (6). It is reported that B
MINI-REVIEW
Salivary gland and autoimmunity
Yoshio Hayashi, Rieko Arakaki, and Naozumi Ishimaru
Department of Oral Molecular Pathology, Institute of Health Biosciences, the University of Tokushima
Graduate School, Tokushima, Japan
Abstract : Recent evidences suggest that the apoptotic pathway plays a central role in tol-
erazing T cells to tissue-specific self antigen, and may drive the autoimmune phenome-
non in the salivary glands. We found that retinoblastoma-associated protein RbAp48 over-
expression induces p53-mediated apoptosis in the salivary glands caused by estrogen
deficiency. We demonstrated that transgenic (Tg) expression of RbAp48 resulted in the
development of autoimmune exocrinopathy resembling Sjögren’s syndrome (SS). CD4+T
cell-mediated autoimmune lesions in the salivary glands were aggravated with age, in
association with autoantibody productions. We obtained evidences that salivary epithe-
lial cells can produce interferon-(IFN-) besides interleukin (IL)-18, which activates
interferon regulatory factor-1 (IRF-1), and class II transactivator (CIITA). Indeed, the
autoimmune lesions into Rag2-/- mice were induced by the adoptive transfer of lymph
node cells from RbAp48-Tg mice. These results indicate a novel immunocompetent role
of epithelial cells that can produce IFN-, resulting in loss of local tolerance prior to de-
veloping gender-based autoimmunity. The studies reviewed the molecular mechanisms
on the development of salivary gland autoimmunity, and gender-related differences in
SS. J. Med. Invest. 56 Suppl. : 185-191, December, 2009
Keywords : Salivary gland, autoimmunity, RbAp48, Sjögren’s syndrome
Received for publication October 27, 2009 ; accepted November
3, 2009.
Address correspondence and reprint requests to Yoshio Hayashi,
DDS, Ph.D., Department of Oral Molecular Pathology, Institute
of Health Biosciences, the University of Tokushima Graduate
School, Kuramoto-cho, Tokushima 770-8504, Japan and Fax :
+81-88-633-7327.
The Journal of Medical Investigation Vol. 56 Supplement 2009
185
cell activation leads to the production of autoanti-
bodies and polyclonal hyper-gammaglobulinaemia
characteristic of SS, and the B cell activation may
account for the increased propensity of these pa-
tients to developing lymphomas (7). BAFF is a
member of the TNF superfamily, and is involved
in B cell maturation and survival. It was found at
increased levels in serum, and salivary tissues of
the patients with SS, and is expressed by T cells
(8). Moreover, BAFF transgenic mice display a phe-
notype similar to SS or SLE (9). These data imply
an important role for T and B cell interaction in the
pathogenesis of salivary gland autoimmunity.
ROLE OF APOPTOSIS
Apoptosis plays an important role in maintaining
T cell repertoire and deletion of autoreactive T cells
(10, 11), and is regulated by a number of gene prod-
ucts that promote cell death or extend cell survival
(12, 13). Fas ligand (FasL) mediates cell death by
cross-linking Fas receptor in apoptosis-sensitive
Fas+ cells (14, 15). It is now evident that the inter-
action of Fas with FasL regulates a large number
of pathophysiological processes of apoptosis includ-
ing autoimmune diseases (16-19). Recent studies
have confirmed the observation that apoptotic cells
in various cell types implicated as the sourse of
autoantigen when stimulated with different proapop-
totic stimuli (20-22). Much evidence shows that β -
cell apoptosis is a fundamental process involved in
the pathogenesis of type 1 diabetes (23, 24). In ad-
dition to apoptosis being the main mechanism by
which β cells are destroyed, β -cell apoptosis has
been implicated in the initiation of type 1 diabetes
mellitus. These studies support that exaggerated β -
cell damage can induce activation of β -cell-specific
T cells. Therefore, the apoptotic cells may be a criti-
cal determinant contributing to the initiation of auto-
immunity by having the capacity to instruct antigen-
presenting cells (APCs) to modulate immune re-
sponses so that the outcome is T cell activation.
Our previous reports identified a 120 kDa α -fodrin
as an important autoantigen in murine and human
SS (25, 26). It has demonstrated definitively the in-
tracellular pathway of Ro, La and α -fodrin autoan-
tigens as a result of apoptosis, suggesting a pos-
sible mechanism by which antigens may be ex-
posed at the cell surface to APCs such as macro-
phages or dendritic cells (DC). Although cleavage
of certain autoantigens during apoptosis may reveal
immunocryptic epitopes that could potentially induce
autoimmune responses in systemic autoimmune dis-
eases (19, 27), accumulated evidences suggest an
important role of apoptosis in the disease patho-
genesis of SS (28, 29). We found that a significant
increase of TUNEL+-apoptotic epithelial duct cells
in the salivary glands was detected in NFS/sld SS
model, compared with those in control mice at all
ages (30). Moreover, we confirmed that tissue-in-
filtrating CD4+ T cells are responsible for tissue de-
struction as judged by in vitro 51Cr release cytotoxic
assay against MSG cells (30). Although it has been
reported that Fas-induced apoptosis seems to be
the major killing pathway of the CD4+ cytotoxic T
cells (31), our data suggest that one mechanism by
which activated CD4+ T cells induce cytotoxicity
towards salivary gland cells in murine SS model is
Fas-based (30). Our recent immunofluorescence
analysis from SS patients demonstrated that a cleav-
age product of α -fodrin was present in epithelial
duct cells of the labial salivary gland biopsies from
SS patients, but not in control glands (26). These
data suggest that increased activity of caspase cas-
cade is involved in the progression of α -fodrin pro-
teolysis during the initial stages on the development
of primary SS.
SALIVARY GLAND AUTOIMMUNITY DE-
VELOPS IN RbAp48-TG MICE
We have generated RbAp48 -Tg mice where the
RbAp48 gene is expressed in the salivary and lacri-
mal glands using the gland-specific promoter (32,
33). When the histopathology of all organs from
those mice were analyzed, we found that autoim-
mune exocrinopathy resembling SS developed in
almost all RbAp48 -Tg mice at 24-wks-old or more,
but not in the wild-type (WT) mice. Lymphocyte
infiltration in salivary glands of RbAp48 -Tg mice be-
comes more frequent at around 30- to 50-wks of
age, and a significantly higher incidence of inflam-
matory lesions was found in female Tg mice at all
ages. Many infiltrating lymphocytes were observed
in periductal areas with varying degrees, and shown
in focal appearance. A majority of infiltrating cells
in salivary and lacrimal glands was Thy1.2+ CD4+ T
cells, while a minor proportion of B220+B cells, CD8+
T cells and CD11b+ cells were observed. When the
function of salivary glands in RbAp48 -Tg mice was
analyzed, the average volume of tear and saliva se-
cretion from RbAp48-Tg mice was significantly lower
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than that from the WT group at 30-wks of age or
more. Regarding the peripheral T cell phenotype
of RbAp48 -Tg mice, T cell activation markers
(CD44high, CD62Llow, CD45RBlow) were up-regulated
on CD4+ T cells in cervical lymph nodes (cLNs) from
RbAp48 -Tg mice, compared with those from WT
mice. As for the phenotype of CD4+CD25+Foxp3+
Treg cells, no difference was detected in thymus,
spleen, and cLNs between RbAp48 -Tg and WT
mice. Moreover, culture supernatants from anti-
TCRβ and -CD28 mAb-stimulated cLN T cells ob-
tained from RbAp48 -Tg mice contained higher lev-
els of interleukin (IL)-2, and interferon-γ (IFN-γ),
while no difference in IL-4, and IL-10 levels be-
tween RbAp48 -Tg and WT mice was observed by
ELISA. Of particular interest is that a higher titer
of serum autoantibodies against SS-A (Ro), SS-B
(La) and 120 kDa α -fodrin was detected in RbAp48 -
Tg mice, compared with that in WT mice by ELISA
(33). This result is consistent with the characteris-
tic flow cytometric finding that showed a significant
CD5+B220+ fraction capable of autoantibody produc-
tion (34) which appeared in spleen cells from
RbAp48 -Tg mice compared to WT mice. In addi-
tion, significantly increased CD21highIgMhighB220+
marginal zone B cells were observed in both cervi-
cal lymph nodes and spleen from RbAp48 -Tg mice
compared with those from WT mice. These results
may provide a new animal model for autoimmune
exocrinopathy resembling SS (33), which should
help us to further understand how autoreactive T
cells are developed, and subsequently influence the
development of autoimmunity.
SALIVARY GLAND EPITHELIAL CELLS AS
ANTIGEN-PRESENTING CELLS
It has been well known that nonlymphoid cells
that express MHC class II molecules provoke auto-
immune responses (35, 36). However, it is undeter-
mined whether MHC class II-expressing epithelial
cells can function as antigen-presenting cells. We
frequently observed MHC class II molecule expres-
sion on the salivary gland cells in RbAp48 -Tg mice,
not in WT mice. The salivary epithelial cells play a
pivotal role in the induction and regulation of im-
mune responses by virtue of their ability to pre-
sent self-peptides to CD4+ T cells (37). To examine
whether salivary epithelial cells could act as anti-
gen-presenting cells, mouse salivary gland (MSG)
cells, splenocytes, and splenic CD11c+ dendritic cells
(DCs) from RbAp48 -Tg mice and WT mice were
compared in terms of their capacity to express MHC
class II, and costimulatory molecules including
CD86, CD80, and ICAM-1 by flow cytometric analy-
sis. Among them, a considerably large proportion
of MHC class II+, CD86+ cells, CD80+ cells, and
ICAM-1+ cells was observed on MSG cells from Tg
mice, compared with those from WT mice (Fig. 1).
MSG cells were enriched by enzymatic treatment,
several antibodies against immune cells and epithe-
lial cells, and magnetic beads. On the other hand,
although the expressions of MHC Class II and
CD86 on the splenocytes and CD11c+ DCs were
higher than those on both MSG cells, the expres-
sions of CD80 and ICAM-1 on the professional
APCs were similar or lower than those on the MSG
Fig. 1. Expression of antigen-presenting cell markers in salivary epithelial cells from RbAp48-Tg mice (Ref. #33). Antigen-
Presenting cell (APC) markers of splenocytes, splenic DCs, and mouse salivary gland (MSG) cells from WT and RbAp48 -Tg mice
were analyzed by flow cytometer using anti -MHC class II, anti -CD86, anti -CD80, and anti - ICAM-1 mAbs..
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cells. These expressions (MHC class II+, CD86+,
CD80+, and ICAM-1+) on salivary epithelial cells
from RbAp48 -Tg mice were also confirmed by con-
focal analysis. Moreover, to examine whether the
peripheral T cells from RbAp48 -Tg mice can re-
spond to the MSG cells that show phenotypes for
the APCs, CFSE-labeled purified CD4+ (1105) T
cells from RbAp48 -Tg mice were co-cultured with
the MSG cells (1, 2105) from those mice or WT
mice. Although CD4+ T cells from B6 mice could
not respond to both B6 and RbAp48 -Tg MSG cells,
CD4+ T cells from RbAp48 -Tg mice were capable
of responding to MSG cells from RbAp48 -Tg mice,
but not with those from WT mice, while anti-MHC
class II antibody inhibits these responses. Further-
more, proliferation assay using [3H]-thymidine in-
corporation demonstrated that purified CD4+ T cells
of cLNs from RbAp48 -Tg mice were more prolifera-
tive to the MSG cells from RbAp48-Tg mice rela-
tive to those from WT mice (33).
CRUCIAL ROLE OF EPITHELIAL IFN-
PRODUCTION
The expression of MHC class II molecules is gen-
erally regulated at the transcriptional levels includ-
ing the transcription factor interferon regulatory fac-
tor (IRF)-1 (38, 39) and the class II transactivator
(CIITA), the master regulator for MHC class II gene
expression (40, 41). It has been shown that IRF-1 is
a primary responsible gene of the IFN-γ response
(42). In in vitro studies using human salivary gland
(HSG) cells (43), IFN-γ - induced mRNAs of IRF-1
and CIITA were significantly enhanced by the treat-
ment of Tamoxifen (Tam), which is an antagonist
of estrogen and can induce RbAp48 (44), or trans-
fection of pCMV-RbAp48 plasmid in the dose-de-
pendent manner, not in MCF-7 cells (human mam-
mary gland cell line). In addition, we analyzed the
IRF-1 promoter activity using RbAp48 -transfected
HSG cells with and without IFN-γ by luciferase
assay. We observed significantly enhanced IRF-1
promoter activity in RbAp48 -transfected HSG cells
with IFN-γ, not in MCF-7 cells. To our surprise, in
RbAp48 -Tg mice, a prominent expression of IFN-γ
was detected in salivary epithelial cells besides spo-
radically positive infiltrating cells of RbAp48 -Tg
mice, not WT mice. These findings were observed
mainly in the MHC class II+ ductal epithelium adja-
cent to lymphoid infiltrates. Epithelial IFN-γ expres-
sion in the exocrine glands of RbAp48 -Tg mice was
up-regulated during the course of autoimmune exo-
crinopathy (33). Induction of IFN-γ expression may
occur through many different types of stimulation,
including cross-linking of cell-surface receptors and
stimulation with cytokines, including IL-2, IL-12,
and IL-18 (44)(34). It has been demonstrated that
IFN-γ synthesis is predominantly induced by stimu-
lation with IL-18 (45). Consistent with a previous
report (46), IL-18 expression was observed in sali-
vary epithelial cells in RbAp48 -Tg mice, not in WT
mice. Confocal analysis revealed that differential ex-
pression of IL-18 and IFN-γ was clearly observed,
i.e. IL-18 mainly in the acinar cells and IFN-γ in
the duct cells, within salivary epithelial cells from
RbAp48 -Tg mice, not from WT mice (Fig. 2). Epi-
thelial IFN-γ and IL-18 productions were confirmed
by flow cytometry using MSG cells without immune
cells from RbAp48 -Tg, not from WT mice, while
there was no difference in both IFN-γ and IL-18 ex-
pressions of cLN cells between WT and RbAp48 -Tg
Fig. 2. IFN-γ and IL-18 production in salivary epithelial cells from RbAp48-Tg mice (Ref. #33). Confocal analysis of IFN-γ, IL-18 or
DAPI of salivary gland tissues from WT and RbAp48 -TG mice at 32 weeks of age. Alexa-488- or Alexa-568-conjugated anti -rat IgG
as the second antibodies were used. Photos are representative of three to five mice.
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mice. Although the production of IL-18 in salivary
gland cells has been detected in a previous report
(46), there has been no proof for IFN-γ production
of salivary gland cells in any report. Therefore, to
confirm IFN-γ production of salivary glands, detec-
tion of IFN-γ using tissue homogenates was per-
formed. High concentration of IFN-γ was detected
in the tissue homogenates of salivary glands from
RbAp48 -Tg mice by ELISA. Furthermore, the de-
tection of IFN-γ mRNA of MSG cells was performed
by in situ hybridization using the RNA probe of
mouse IFN-γ gene. More intensive signal for IFN-γ
mRNA in duct cells of salivary glands from RbAp48 -
Tg mice was observed compared with that from
WT mice. In vitro studies using HSG cells demon-
strated that the expressions of IL-18, IFN-γ and
MHC class II (HLA -DR) were observed when
treated with Tam or transfected with pCMV-RbAp48 ,
while they were inhibited when treated with 17β -
estradiol (E2), caspase 1 inhibitor (Ac-YVAD-CHO)
(Ci), and siRNA of RbAp48 (si). Confocal analysis
confirmed the expressions of IL-18, and IFN-γ in
HSG cells treated with Tam or transfected with
pCMV-RbAp48 . It is important to note that IL-18 is
secreted earlier (by 6 hours) than IFN-γ produc-
tion and HLA-DR expression (by 12 hours) in Tam-
stimulated and RbAp48 -transfected HSG cells.
CONCLUDING REMARKS
We demonstrated that autoimmune exocrinopa-
thy resembling SS developed in almost all RbAp48 -
Tg mice, and that a high titer of serum autoantibod-
ies against SS-A (Ro), SS-B (La) and 120 kDa α -
fodrin was detected in these Tg mice. We found
frequently MHC class II molecule expression on the
exocrine gland cells with autoimmune lesions in
RbAp48 -Tg mice. Although it has been undeter-
mined whether MHC class II-expressing epithelial
cells can function as antigen-presenting cells, our
data strongly suggest that the epithelial cells may
function as antigen-presenting cells during devel-
opment of autoimmunity. In RbAp48 -Tg mice, a
prominent expression of epithelial IFN-γ was de-
tected besides sporadically positive infiltrating cells.
These findings were observed mainly in the MHC
class II+ ductal epithelium. Epithelial IFN-γ expres-
sion in the salivary glands was up-regulated during
the course of autoimmune exocrinopathy. These
data demonstrate a direct molecular mechanism by
which estrogen deficiency induces tissue-specific
overexpression of RbAp48, subsequently develop-
ing CD4+ T cell-mediated autoimmunity through
epithelial IFN-γ production. Thus, reducing the
RbAp48 overexpression is a possible effective ther-
apy for gender-based autoimmunity in the salivary
glands.
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